Primary |
Parkinson's Disease |
75.3% |
Depression |
2.9% |
Hypertension |
2.8% |
Parkinsonism |
2.2% |
Restless Legs Syndrome |
2.2% |
Diabetes Mellitus |
1.5% |
Dystonia |
1.5% |
Sleep Disorder |
1.3% |
Product Used For Unknown Indication |
1.2% |
Tremor |
1.1% |
Anxiety |
1.0% |
Back Pain |
1.0% |
Insomnia |
0.8% |
Cardiac Disorder |
0.7% |
Cardiac Failure |
0.7% |
Multiple Myeloma |
0.7% |
Osteoporosis |
0.7% |
Pain |
0.7% |
Postpartum Hypopituitarism |
0.7% |
Constipation |
0.6% |
|
Drug Ineffective |
13.4% |
Tremor |
8.0% |
Death |
7.0% |
Hallucination |
7.0% |
Dyskinesia |
6.7% |
Wrong Technique In Drug Usage Process |
6.7% |
Somnolence |
6.4% |
Vomiting |
5.7% |
Parkinson's Disease |
5.4% |
Nausea |
4.5% |
Neuroleptic Malignant Syndrome |
3.8% |
Weight Decreased |
3.8% |
Overdose |
3.5% |
Pharmaceutical Product Complaint |
3.2% |
Drug Effect Decreased |
2.9% |
Adverse Event |
2.5% |
Rhabdomyolysis |
2.5% |
Therapeutic Response Decreased |
2.5% |
Drug Interaction |
2.2% |
Movement Disorder |
2.2% |
|
Secondary |
Parkinson's Disease |
64.0% |
Drug Use For Unknown Indication |
9.5% |
Product Used For Unknown Indication |
4.5% |
Hypertension |
3.9% |
Depression |
2.6% |
Psychotic Disorder |
2.1% |
Parkinsonism |
1.7% |
Restless Legs Syndrome |
1.7% |
Pain |
1.4% |
Diabetes Mellitus |
1.1% |
Anxiety |
1.1% |
Back Pain |
0.8% |
Cardiac Disorder |
0.8% |
Prophylaxis |
0.8% |
Hypothyroidism |
0.7% |
Gastric Ulcer |
0.7% |
Tetrahydrobiopterin Deficiency |
0.7% |
Dyskinesia |
0.6% |
Endocarditis |
0.6% |
Hallucination, Visual |
0.6% |
|
Tremor |
11.2% |
Pathological Gambling |
9.5% |
Wrong Technique In Drug Usage Process |
9.5% |
Abnormal Behaviour |
6.3% |
Parkinson's Disease |
6.3% |
Somnolence |
6.3% |
Dyskinesia |
5.6% |
Hallucination |
5.3% |
Speech Disorder |
3.9% |
Sudden Onset Of Sleep |
3.9% |
Tubulointerstitial Nephritis |
3.9% |
Weight Decreased |
3.9% |
Wrist Fracture |
3.6% |
Hallucination, Visual |
3.3% |
Syncope |
3.3% |
Vomiting |
3.3% |
Pulmonary Embolism |
3.0% |
Nausea |
2.6% |
Orthostatic Hypotension |
2.6% |
Overdose |
2.6% |
|
Concomitant |
Parkinson's Disease |
40.0% |
Product Used For Unknown Indication |
12.0% |
Drug Use For Unknown Indication |
8.0% |
Depression |
5.7% |
Restless Legs Syndrome |
4.7% |
Hypertension |
4.7% |
Pain |
3.9% |
Osteoporosis |
2.5% |
Anxiety |
2.2% |
Insomnia |
2.1% |
Gastrooesophageal Reflux Disease |
2.0% |
Diabetes Mellitus |
1.7% |
Constipation |
1.6% |
Back Pain |
1.6% |
Prophylaxis |
1.5% |
Dementia |
1.5% |
Blood Cholesterol Increased |
1.2% |
Atrial Fibrillation |
1.2% |
Ill-defined Disorder |
1.0% |
Rheumatoid Arthritis |
1.0% |
|
Pathological Gambling |
10.9% |
Tremor |
8.5% |
Somnolence |
8.3% |
Parkinson's Disease |
7.6% |
Weight Decreased |
7.2% |
Death |
6.3% |
Weight Increased |
6.2% |
Vomiting |
5.3% |
Suicidal Ideation |
4.5% |
Urinary Tract Infection |
4.5% |
Syncope |
4.1% |
Pneumonia |
3.7% |
Vision Blurred |
3.7% |
Drug Ineffective |
3.6% |
Hallucination |
2.8% |
Road Traffic Accident |
2.8% |
Nausea |
2.6% |
Wrong Drug Administered |
2.6% |
Pain In Extremity |
2.5% |
Pharmaceutical Product Complaint |
2.4% |
|
Interacting |
Parkinson's Disease |
39.4% |
Drug Use For Unknown Indication |
10.6% |
Back Pain |
9.1% |
Depression |
4.3% |
Osteoporosis |
3.8% |
Arthralgia |
3.4% |
Iron Deficiency |
3.4% |
Diabetes Mellitus |
2.9% |
Enterococcal Infection |
2.9% |
Pernicious Anaemia |
2.9% |
Quadriplegia |
2.9% |
Hypertension |
2.4% |
Pain |
2.4% |
Product Used For Unknown Indication |
1.9% |
Type 2 Diabetes Mellitus |
1.9% |
Anxiety |
1.4% |
Ovarian Cancer |
1.4% |
Essential Hypertension |
1.0% |
Hypercholesterolaemia |
1.0% |
Nausea |
1.0% |
|
Pulmonary Embolism |
10.9% |
Weight Decreased |
9.1% |
Drug Interaction |
7.3% |
Parkinson's Disease |
7.3% |
Tremor |
7.3% |
Haemorrhage |
5.5% |
Headache |
5.5% |
Nausea |
5.5% |
Sleep Disorder |
5.5% |
Faeces Discoloured |
3.6% |
Insomnia |
3.6% |
Oedema |
3.6% |
Orthostatic Hypotension |
3.6% |
Parkinsonism |
3.6% |
Presyncope |
3.6% |
Psychomotor Retardation |
3.6% |
Unresponsive To Stimuli |
3.6% |
Urinary Incontinence |
3.6% |
Agitation |
1.8% |
Confusional State |
1.8% |
|